Baotou Dongbao Bio-Tech Co.,Ltd provided earnings guidance for the first three quarter of 2014. For the period, the company expected net profit attributable to shareholders to be in the range of CNY 2.6 million to CNY 4 million, declining 88.16% to 92.31% from CNY 33.7926 million a year earlier.